The application of Aptamer in biomarker discovery

Y Li, WW Tam, Y Yu, Z Zhuo, Z Xue, C Tsang, X Qiao… - Biomarker …, 2023 - Springer
Biomarkers are detectable molecules that can reflect specific physiological states of cells,
organs, and organisms and therefore be regarded as indicators for specific diseases. And …

Research progress in the molecular mechanisms, therapeutic targets, and drug development of idiopathic pulmonary fibrosis

H Ma, X Wu, Y Li, Y ** spatially resolved transcriptomes in human and mouse pulmonary fibrosis
L Franzén, M Olsson Lindvall, M Hühn, V Ptasinski… - Nature Genetics, 2024 - nature.com
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease with poor prognosis and
limited treatment options. Efforts to identify effective treatments are thwarted by limited …

H3K18 lactylation promotes the progression of arsenite-related idiopathic pulmonary fibrosis via YTHDF1/m6A/NREP

P Wang, D **e, T **ao, C Cheng, D Wang, J Sun… - Journal of Hazardous …, 2024 - Elsevier
As epigenetic modifications, lactylation and N6-methyladenosine (m6A) have attracted wide
attention. Arsenite is an environmental pollutant that has been proven to induce idiopathic …

ROS-responsive liposomes as an inhaled drug delivery nanoplatform for idiopathic pulmonary fibrosis treatment via Nrf2 signaling

J Liu, Z Wu, Y Liu, Z Zhan, L Yang, C Wang… - Journal of …, 2022 - Springer
Background Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic disease with
pathophysiological characteristics of transforming growth factor-β (TGF-β), and reactive …

Nintedanib ameliorates bleomycin-induced pulmonary fibrosis, inflammation, apoptosis, and oxidative stress by modulating PI3K/Akt/mTOR pathway in mice

L Pan, Y Cheng, W Yang, X Wu, H Zhu, M Hu, Y Zhang… - Inflammation, 2023 - Springer
Idiopathic pulmonary fibrosis (IPF) seriously threatens human life and health, and no
curative therapy is available at present. Nintedanib is the first agent approved by the US …

[HTML][HTML] The impact of formaldehyde exposure on lung inflammatory disorders: insights into asthma, bronchitis, and pulmonary fibrosis

AA Bhat, M Afzal, A Goyal, G Gupta, R Thapa… - Chemico-biological …, 2024 - Elsevier
Lung inflammatory disorders are a major global health burden, impacting millions of people
and raising rates of morbidity and death across many demographic groups. An industrial …

Inhaled lipid nanoparticles alleviate established pulmonary fibrosis

D Li, A Zhao, J Zhu, C Wang, J Shen, Z Zheng, F Pan… - Small, 2023 - Wiley Online Library
Pulmonary fibrosis, a sequela of lung injury resulting from severe infection such as severe
acute respiratory syndrome‐like coronavirus (SARS‐CoV‐2) infection, is a kind of life …

Lung injury-induced activated endothelial cell states persist in aging-associated progressive fibrosis

AA Raslan, TX Pham, J Lee, K Kontodimas… - Nature …, 2024 - nature.com
Progressive lung fibrosis is associated with poorly understood aging-related endothelial cell
dysfunction. To gain insight into endothelial cell alterations in lung fibrosis we performed …

Lactylation: novel epigenetic regulatory and therapeutic opportunities

H Fan, F Yang, Z **ao, H Luo, H Chen… - American Journal …, 2023 - journals.physiology.org
Lactate, which is an end product of glycolysis, has traditionally been considered a metabolic
waste. However, numerous studies have demonstrated that lactate serves metabolic and …